Candidate Metastasis-associated Genes of the Rat 13762NF Mammary Adenocarcinoma

Overview

Journal Breast Cancer Res Treat

Specialty Oncology

Date 1993 Jan 1

PMID 8347848

Citations 30

Authors

S D Pencil

Y Toh

G L Nicolson

Affiliations

Soon will be listed here.

Abstract

Differential hybridization was used to isolate genes potentially involved in the process of metastasis. Ten complementary DNAs (cDNAs) that were differentially expressed between a highly metastatic (MTLn3) and a nonmetastatic (MTC.4) line of the rat 13762NF mammary adenocarcinoma were isolated and sequenced. Examination of the EMBL/GenBank database revealed that one of the genes had a high degree of homology (98.8%) to annexin I (also known as calpactin II). Quantitative analysis of Northern blot hybridizations showed that the annexin I-like sequence was expressed 4- to 7-fold higher in MTLn3 than in MTC.4 cells. Steady state mRNA levels were also low in MTLn2, a cell line of low metastatic potential closely related to MTLn3, but were not related to metastatic potential in colon adenocarcinoma or melanoma cells. Two of the cDNAs (designated 8.11 and 10.14) were found to be novel. The expression of 10.14 mRNA (3.2 kb) was 4-fold higher in MTLn3 than in MTC.4 cells. Sequencing of the 10.14 cDNA (2.2 kb) revealed a putative open reading frame of 583 amino acids that was also novel. Expression of 8.11 mRNA (> 7 kb) inversely correlated with metastatic potential. Another differentially transcribed gene was highly homologous to ERK2 (extracellular signal related kinase 2), a mitogen-activated protein kinase (MAPK). Northern analysis of ERK2 expression revealed 3-fold higher amounts of a 1.3 kb mRNA in MTLn3 than in MTC.4 cells. Higher levels of ERK2 mRNA were generally seen in the more metastatic human colon but not in melanoma cell lines. We also corroborated the work of Taniguchi (Nucl Acids Res 19:6949, 1991) by independently identifying EF-1 alpha as a putative metastasis-associated gene.

Citing Articles

Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.

Li C, Wang Z, Yao L, Lin X, Jian Y, Li Y Nat Commun. 2024; 15(1):2163.

PMID: 38461299 PMC: 10924921. DOI: 10.1038/s41467-024-46422-5.

In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.

Grzeskowiak C, Kundu S, Mo X, Ivanov A, Zagorodna O, Lu H Nat Commun. 2018; 9(1):2732.

PMID: 30013058 PMC: 6048166. DOI: 10.1038/s41467-018-04572-3.

[Regulation Mechanism of MTA3 in the Apoptosis of NSCLC Cells].

Li H, Wang Q, Zhang L, Bao H, Zhang H Zhongguo Fei Ai Za Zhi. 2015; 18(10):610-5.

PMID: 26483332 PMC: 6000090. DOI: 10.3779/j.issn.1009-3419.2015.10.02.

Structure and function insights into the NuRD chromatin remodeling complex.

Torchy M, Hamiche A, Klaholz B Cell Mol Life Sci. 2015; 72(13):2491-507.

PMID: 25796366 PMC: 11114056. DOI: 10.1007/s00018-015-1880-8.

The subcellular distribution and function of MTA1 in cancer differentiation.

Liu J, Xu D, Wang H, Zhang Y, Chang Y, Zhang J Oncotarget. 2014; 5(13):5153-64.

PMID: 24970816 PMC: 4148129. DOI: 10.18632/oncotarget.2095.

References

Tobe K, Kadowaki T, Tamemoto H, Ueki K, Hara K, Koshio O . Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues. J Biol Chem. 1991; 266(36):24793-803. View

Yeatman T, Updyke T, Kaetzel M, Dedman J, Nicolson G . Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis. 1993; 11(1):37-44. DOI: 10.1007/BF00880064. View

Neri A, Nicolson G . Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro. Int J Cancer. 1981; 28(6):731-8. DOI: 10.1002/ijc.2910280612. View

Jones J, Segall J, Condeelis J . Molecular analysis of amoeboid chemotaxis: parallel observations in amoeboid phagocytes and metastatic tumor cells. EXS. 1991; 59:1-16. DOI: 10.1007/978-3-0348-7494-6_1. View

Taniguchi S, Miyamoto S, Sadano H, Kobayashi H . Rat elongation factor 1 alpha: sequence of cDNA from a highly metastatic fos-transferred cell line. Nucleic Acids Res. 1991; 19(24):6949. PMC: 329333. DOI: 10.1093/nar/19.24.6949. View

Dear T, McDonald D, Kefford R . Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells. Cancer Res. 1989; 49(19):5323-8. View

Huhtala P, Chow L, Tryggvason K . Structure of the human type IV collagenase gene. J Biol Chem. 1990; 265(19):11077-82. View

Nakajima M, Welch D, Belloni P, Nicolson G . Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 1987; 47(18):4869-76. View

Lichtner R, Moskwa P, Nicolson G . Heterogeneous expression of cytokeratins in metastatic mammary adenocarcinoma cells in vitro and in vivo. Invasion Metastasis. 1987; 7(6):367-83. View

10.

Shimizu Y, Takabayashi E, Yano S, Shimizu N, Yamada K, Gushima H . Molecular cloning and expression in Escherichia coli of the cDNA coding for rat lipocortin I (calpactin II). Gene. 1988; 65(1):141-7. DOI: 10.1016/0378-1119(88)90427-1. View

11.

Barnes J, Michiel D, Hollenberg M . Simultaneous phosphorylation of three human calpactins by kinase C. Biochem Cell Biol. 1991; 69(2-3):163-9. DOI: 10.1139/o91-024. View

12.

Crews C, Alessandrini A, Erikson R . Erks: their fifteen minutes has arrived. Cell Growth Differ. 1992; 3(2):135-42. View

13.

Chauhan S, Goldstein L, Gottesman M . Expression of cathepsin L in human tumors. Cancer Res. 1991; 51(5):1478-81. View

14.

Yagel S, WARNER A, Nellans H, Lala P, Waghorne C, Denhardt D . Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res. 1989; 49(13):3553-7. View

15.

Fidler I . Selection of successive tumour lines for metastasis. Nat New Biol. 1973; 242(118):148-9. DOI: 10.1038/newbio242148a0. View

16.

Schwartz G, Redwood S, Ohnuma T, HOLLAND J, Droller M, Liu B . Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst. 1990; 82(22):1753-6. DOI: 10.1093/jnci/82.22.1753. View

17.

Horlick K, Ganjianpour M, Frost S, Nick H . Annexin-I regulation in response to suckling and rat mammary cell differentiation. Endocrinology. 1991; 128(3):1574-9. DOI: 10.1210/endo-128-3-1574. View

18.

Gopalakrishna R, Barsky S . Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci U S A. 1988; 85(2):612-6. PMC: 279601. DOI: 10.1073/pnas.85.2.612. View

19.

Steeg P, Bevilacqua G, Kopper L, Thorgeirsson U, Talmadge J, Liotta L . Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988; 80(3):200-4. DOI: 10.1093/jnci/80.3.200. View

20.

Gotoh Y, Nishida E, Yamashita T, Hoshi M, Kawakami M, Sakai H . Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells. Eur J Biochem. 1990; 193(3):661-9. DOI: 10.1111/j.1432-1033.1990.tb19384.x. View